20 May 2013
Keywords: protherics, updates, voraxaze, progress, uk, biopharmaceuticals, firm
Article | 15 January 2007
UK biopharmaceuticals firm Protherics has issued an update on its progress in the USA and Europe with Voraxaze (glucarpidase), an ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.